XMT-2056, a HER2-Directed STING Agonist Antibody–Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
Raghida A. Bukhalid(Mersana Therapeutics (United States)), Timothy B. Lowinger(Mersana Therapeutics (United States))
Cited by 32
Related Papers
No related papers found
Powered by citation graph analysis